In this study, we used a stereotactic injection technique to inject mice with AAV-shTMEM106B to reduce the expression of TMEM106B in the SN of mice, followed by intraperitoneal injection of MPTP to establish a mouse model of PD. This evidence concerns the gene TMEM106B and Parkinson disease.